BRIEF published on 04/29/2026 at 13:05, 9 days 4 hours ago Cheplapharm prévoit une croissance de son chiffre d'affaires en 2025 Croissance Des Revenus Marge D'EBITDA Stabilité Financière Industrie Pharmaceutique CHEPLAPHARM
BRIEF published on 04/29/2026 at 13:05, 9 days 4 hours ago Cheplapharm Sees Revenue Growth in 2025 Pharmaceutical Industry Revenue Growth EBITDA Margin Financial Stability CHEPLAPHARM
PRESS RELEASE published on 04/29/2026 at 13:00, 9 days 4 hours ago CHEPLAPHARM reports Revenue Growth in the 2025 Financial Year CHEPLAPHARM reports 8.1% revenue growth reaching €1.66 billion in FY2025. EBITDA at €642.8 million with a 38.8% margin. Employee count up 2% to 799 Financial Results EBITDA Revenue Growth CHEPLAPHARM Employee Count
BRIEF published on 02/02/2026 at 15:41, 3 months 6 days ago CHEPLAPHARM's Successful €950m Bond Issuance Refinancing Bond Issuance Financial Strategy Investor Demand CHEPLAPHARM
BRIEF published on 02/02/2026 at 15:41, 3 months 6 days ago L'émission obligataire de 950 millions d'euros de CHEPLAPHARM est un succès Stratégie Financière Emission D'obligations Refinancement Demande Des Investisseurs CHEPLAPHARM
PRESS RELEASE published on 02/02/2026 at 15:36, 3 months 6 days ago Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed CHEPLAPHARM successfully refinances with new 6.750% bond oversubscribed multiple times, enhancing financial flexibility and maturity profile Refinancing Oversubscribed Financial Flexibility CHEPLAPHARM 6.750% Bond
BRIEF published on 08/27/2025 at 13:34, 8 months 12 days ago CHEPLAPHARM Reports Stable Growth in the First Half of 2025 Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
BRIEF published on 08/27/2025 at 13:34, 8 months 12 days ago CHEPLAPHARM annonce une croissance stable au premier semestre 2025 Croissance Des Revenus Industrie Pharmaceutique CHEPLAPHARM Programme De Transformation Expansion Des Employés
PRESS RELEASE published on 08/27/2025 at 13:29, 8 months 12 days ago CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024 Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG
BRIEF published on 06/26/2025 at 10:36, 10 months 12 days ago L'obligation de 750 millions d'euros de CHEPLAPHARM connaît une forte demande et un prix attractif Obligations Confiance Des Investisseurs Médicaments Flexibilité Financière CHEPLAPHARM
Published on 05/08/2026 at 15:55, 2 hours 2 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 2 hours 57 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 3 hours 2 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 3 hours 27 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 3 hours 57 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 17:00, 57 minutes ago Drägerwerk AG & Co. KGaA: Dräger’s annual shareholders’ meeting resolves on a significant dividend increase
Published on 05/08/2026 at 16:35, 1 hour 22 minutes ago Edison issues report on Canadian General Investments (CGI)
Published on 05/08/2026 at 16:15, 1 hour 42 minutes ago Inaugural Global Mediation Summit boosts Hong Kong’s status as a global mediation hub
Published on 05/08/2026 at 16:15, 1 hour 42 minutes ago Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Published on 05/08/2026 at 16:15, 1 hour 42 minutes ago DATAGROUP Acquires Dutch IT Service Provider Valid Managed Services
Published on 05/07/2026 at 19:15, 22 hours 42 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 22 hours 42 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 22 hours 51 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 22 hours 51 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 22 hours 57 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
